Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients

Bauer, 1993, Identification of differentially expressed mRNA tests by an improved display technique (DDRT-PCR), Nucleic Acids Research, 21, 4272, 10.1093/nar/21.18.4272 Brandt, 2000, Candida. dubliniensis fungemia, Emerging Infectious Diseases, 6, 46, 10.3201/eid0601.000108 Coleman, 1997, Candidiasis, AIDS, 11, 557, 10.1097/00002030-199705000-00002 Donnelly, 1999, Phylogenetic analysis and rapid identificati6on of Candida dubliniensis based on analysis of ACT1 intron and exon sequences, Microbiology, 145, 1871, 10.1099/13500872-145-8-1871 Fell, 1993, Rapid identification of yeast species using three primers in a polymerase chain reaction, Molecular Marine Biology and Biotechnology, 2, 174 Gallagher, 1992, Reduced azole susceptibility of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation, J General Microbiology, 138, 1901, 10.1099/00221287-138-9-1901 Jabra-Rizk, 1999, Identification of Candida dubliniensis in a prospective study of patients in the United States, J Clinical Microbiology, 37, 321, 10.1128/JCM.37.2.321-326.1999 Kirkpatrick, 1998, Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates, J Clinical Microbiology, 36, 3007, 10.1128/JCM.36.10.3007-3012.1998 Meiller, 1999, Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States, Oral Surgery Oral Medecine, Oral Pathology, Oral Radiology, Endodontics, 88, 573, 10.1016/S1079-2104(99)70088-0 Milan, 1998, Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure, Diagnostic Microbiological Infectious Disease, 32, 211, 10.1016/S0732-8893(98)00107-2 National Committee for Clinical Laboratory Standards (1997). Reference method for broth microdilution antifungal susceptibility testing of yeasts: document M27A. Villanova PA. Document M27A. Odds, 1998, Prevalence of Candida dubliniensis isolates in a yeast stock collection, Journal of Clinical Microbiology, 36, 2869, 10.1128/JCM.36.10.2869-2873.1998 Rodriguez-Tudela, 1995, Correlation of in-vitro susceptibility test results with clinical response, Journal of Antimicrobial Chemotherapy, 35, 793, 10.1093/jac/35.6.793 Sano, 2000, Isolation of Candida. dubliniensis from the oral cavity of an HIV-positive child in Brazil, Nippon Ishinkin Gakkai Zasshi, 41, 177, 10.3314/jjmm.41.177 Schoofs, 1997, Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients, European Journal of Clinical Microbiology of Infectious Disease, 16, 296, 10.1007/BF01695634 Sullivan, 1997, Candida dubliniensis, Current Topics in Medical Mycology, 8, 15 Sullivan, 1997, Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals, Journal of Clinical Microbiology, 35, 960, 10.1128/jcm.35.4.960-964.1997 Sullivan, 1999, Candida dubliniensis, Rev Iberoam Micology, 16, 72 Sullivan, 1995, Candida dubliniensis sp. nov., Microbiology, 141, 1507, 10.1099/13500872-141-7-1507 Wach, 1994, Procedures for isolating yeast DNA for different purposes Warren, 1995, Candida, Cryptococcus and other yeasts of medical importance, 723 Willis, 2000, Isolation of C. dubliniensis from insulin-using diabetes mellitus patients, Journal of Oral Pathologic Medicine, 29, 86, 10.1034/j.1600-0714.2000.290206.x